|
|
||||||||
1 Department of Oral and Maxillofacial-Pathology, Ragas Dental College and Hospital, 2/102 East Coast Road, Uthandi, Chennai 600 119, India; and
2 Statistician, Ragas Dental College and Hospital, Chennai, India
Correspondence: * corresponding author, ran2{at}vsnl.com
| Abstract |
|---|
|
|
|---|
KEY WORDS: Oral lesion prevalence HIV candidiasis India
| Introduction |
|---|
|
|
|---|
HIV-related oral lesions are frequent and often an early finding in HIV infection. They affect the quality of life of the patient and are useful markers of disease progression and immunosuppression, and their importance has been demonstrated in many studies (Greenspan, 1997; Margiotta et al., 1999; Patton et al., 1999).
A review of literature shows that the reports of oral lesions from developing countries are few when compared with those from developed countries. Also, the study designs and diagnostic criteria are varied. However, this is rapidly changing, as increasing numbers of investigators from different developing countries are publishing well-designed studies. This report summarizes the findings of these studies. The objective of this work was to ascertain the nature and prevalence of oral lesions in different regions, and to identify any gaps in ourunderstanding of these lesions in HIV disease.
| Methods |
|---|
|
|
|---|
|
| Results |
|---|
|
|
|---|
|
|
Oral hairy leukoplakia (OHL) has been reported from all regions. A prevalence of 43% was reported from Mexico (Gillespie and Marino, 1993). A high of 20% has been reported from Africa (Arendorf et al., 1998) and 36% from Thailand (Kerdpon et al., 2004). Reports from India indicate a lower frequency of around 27% (Anil and Challacombe, 1997; Ranganathan et al., 2000, 2004). In the pediatric group, the reported frequency for OHL was 1% from Brazil and South Africa (Santos et al., 2001; Naidoo and Chikte, 2004) to 7% from Thailand (Khongkunthian et al., 2001; Reichart et al., 2003).
Gingivitis and periodontitis associated with HIV infectionlinear gingival erythema (Fig. 2
), necrotizing ulcerative periodontitis (Fig. 3
)have been reported from the different regions, with frequencies ranging from 26% and 128%, respectively. Necrotizing ulceratve gingivitis (Fig. 4
) has been reported only from Africa and Argentina. In the pediatric group, a frequency of 2% linear gingival erythema has been reported from Brazil (Fonseca et al., 2000).
|
|
|
Oral Kaposis sarcoma (Fig. 5
) was not reported from India or Thailand in the series reviewed here. In contrast, a frequency of 52% has been reported from Mexico (Ramirez-Amador et al., 1993) and 19% from Zimbabwe (Chidzonga, 2003).
|
Salivary gland disease was reported in the series from Africa and Thailand. These include xerostomia and enlargement of salivary glands. A surprisingly high frequency of around 47% has been reported from Tanzania in adults 2745 years old (Matee et al., 2000). In the pediatric group, the occurrence of salivary gland disease was 7% in Ugandan children under 18 months of age (Bakaki et al., 2001) and 50% in the South African cohort (Naidoo and Chikte, 2004).
Other oral lesions that have been reported include histoplasmosis (Nittayananta and Chungpanich, 1997; Kerdpon et al., 2004), penicilliosis (Nittayananta and Chungpanich, 1997), lymphoma (Nittayananta and Chungpanich, 1997; Arendorf et al., 1998; Kamiru and Naidoo, 2002; Ramirez-Amador et al., 2003), and oral squamous cell carcinoma (Anil and Challacombe, 1997). In the pediatric group, Molluscum contagiosum was seen in 21% of 71 children from South Africa (Naidoo and Chikte, 2004).
The individual oral lesions are listed by geographical location in Table 3
. The range of prevalence from different regions is shown.
|
| Discussion |
|---|
|
|
|---|
Oral candidiasis is the most common opportunistic infection encountered in both adult and pediatric populations in different regions. At present, it is usually effectively managed by antifungal medication. However, given its prevalence, it may not be too far in the future that we may encounter development of strains resistant to existing anti-fungal medications. Further research is needed to ascertain the strains in resource-poor countries, as well as drug sensitivity, and differences in the organisms, if any, from those in developed countries.
Among resource-poor continents, KS has been reported only from Africa and Latin America, due to the endemic presence of HHV-8. In Asian countries, particularly India, KS has not been reported, since HHV-8 is not endemic in this population.
Oral submucous fibrosis (OSMF) reported from India was due to the habit of areca nut chewing, a common habit in this part of the world, but it is not clear whether the frequency of OSMF is actually raised with HIV infection.
HIV salivary gland disease in adults (Tukutuku et al., 1990; Mugaruka et al., 1991; Hodgson, 1997; Arendorf et al., 1998; Matee et al., 2000; Chidzonga, 2003) and children (Bakaki et al., 2001; Naidoo and Chikte, 2004) has been reported from Africa. Though the reason for the high prevalence is not known, it has been suggested that this could be due to the presence of HLA-DR5 and untreated advanced-stage disease in Africans (McArthur et al., 2003).
The highest prevalence of xerostomia (63%) has been reported from Thailand (Nittayananta and Chungpanich, 1997), but it is highly likely that this was because all the patients were hospitalized and in the advanced stage of the disease, rather than being attributable to a direct association with salivary gland disease.
Histoplasmosis (Nittayananta and Chungpanich, 1997; Kerdpon et al., 2004) and penicilliosis caused by Penicillium marneffei (Nittayananta and Chungpanich, 1997) are endemic to Southeast Asia and are associated with severe immunosuppression. In both these studies, all the patients were in the advanced stage of the disease.
Periodontal lesions and gingivitis were more prevalent in Africa and India, due to poor nutrition and inadequate oral hygiene practices. However, there was much variation in the diagnostic criteria used. Consequently, there is a need for standardization of diagnostic criteria and assessment of outcome measures that can be easily taught, implemented, and reproduced in the resource-constrained setting of developing countries.
The variations reported in prevalence studies summarized here could be due to various factors that include race, gender, age, risk behaviors, geographical location, socio-economic and immune status, duration of HIV infection, medication, method of subject selection, number of subjects examined, diagnostic criteria used, and timing of evaluation of subjects (Patton et al., 2000).
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Anteyi KO, Thacher TD, Yohanna S, Idoko JI (2003). Oral manifestations of HIV-AIDS in Nigerian patients. Int J STD AIDS 14:395398.[Medline]
Arendorf TM, Bredekamp B, Cloete C, Wood R, OKeefe E (1997). Intergroup comparisons of oral lesions in HIV-positive South Africans. Oral Dis 3(Suppl 1):S54S57.
Arendorf TM, Bredekamp B, Cloete CA, Sauer G (1998). Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 27:176179.[Medline]
Bakaki P, Kayita J, Moura Machado JE, Coulter JB, Tindyebwa D, Ndugwa CM, et al. (2001). Epidemiologic and clinical features of HIV-infected and HIV-uninfected Ugandan children younger than 18 months. J Acquir Immune Defic Syndr 28:3542.[Medline]
Butt FM, Chindia ML, Vaghela VP, Mandalia K (2001). Oral manifestations of HIV/AIDS in a Kenyan provincial hospital. East Afr Med J 78:398401.[Medline]
Chidzonga MM (2003). HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 9:317322.[Medline]
EC Clearinghouse (1993). Oral problems related to HIV infection and WHO collaborating centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 22:289291.[Medline]
Fonseca R, Cardoso AS, Pomarico I (2000). Frequency of oral manifestations in children infected with human immunodeficiency virus. Quintessence Int 31:419422.[Medline]
Gillespie GM, Marino R (1993). Oral manifestations of HIV infection: a Pan American perspective. J Oral Pathol Med 22:27.[Medline]
Greenspan JS (1997). Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease. Oral Dis 3(Suppl 1):S13S17.
Hodgson TA (1997). HIV-associated oral lesions: prevalence in Zambia. Oral Dis 3(Suppl 1):S46S50.
Itula PF, Mackenzie SB, Lewis K, Mortimer PP (1997). Orofacial manifestations and seroprevalence of HIV infection in Namibian dental patients. Oral Dis 3(Suppl 1):S51S53.
Kamiru HN, Naidoo S (2002). Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho. S Afr Dent J 57:479482.
Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kampoo K, Sretrirutchai S, et al. (2004). Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 10:138144.[Medline]
Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA (2001). Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med 30:549552.[Medline]
Magalhaes MG, Bueno DF, Serra E, Goncalves R (2001). Oral manifestations of HIV positive children. J Clin Pediatr Dent 25:103106.[Medline]
Margiotta V, Campisi G, Mancuso S, Accurso V, Abbadessa V (1999). HIV infection: oral lesions, CD4+ cell count and viral load in Italian study population. J Oral Pathol Med 28:173177.[Medline]
Matee MI, Scheutz F, Moshy J (2000). Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 6:106111.[Medline]
McArthur CP, Africa CW, Castellani WJ, Luangjamekorn NJ, McLaughlin M, Subtil-De Oliveira A, et al. (2003). Salivary gland disease in HIV/AIDS and primary Sjögrens syndrome: analysis of collagen I distribution and histopathology in American and African patients. J Oral Pathol Med 32:544551.[Medline]
Merchant RH, Oswal JS, Bhagwat RV, Karkare J (2001). Clinical profile of HIV infection. Indian Pediatr 38:239246.[Medline]
Mugaruka Z, Perriens JH, Kapita B, Piot P (1991). Oral manifestations of HIV-1 infection in Zairian patients. AIDS 5:237238.[Medline]
Naidoo S, Chikte U (2004). Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 10:1318.[Medline]
National AIDS Control Organization (2004). Combating HIV/AIDS in India. October 2003. http://www.nacoonline.org
Nittayananta W, Chungpanich S (1997). Oral lesions in a group of Thai people with AIDS. Oral Dis 3(Suppl 1):S41S45.
Nittayananta W, Chanowanna N, Sripatanakul S, Winn T (2001). Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. J Oral Pathol Med 30:224230.[Medline]
Patton LL, McKaig RG, Eron JJ Jr, Lawrence HP, Strauss RP (1999). Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 13:21742176.[Medline]
Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr (2000). Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:299304.[Medline]
Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL (2002). Prevalence and classification of HIV-associated oral lesions. Oral Dis 8(Suppl 2):98109.
Pongsiriwet S, Iamaroon A, Kanjanavanit S, Pattanaporn K, Krisanaprakornkit S (2003). Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Paediatr Dent 13:180185.[Medline]
Ramirez-Amador V, Gonzalez M, de la Rosa E, Esquivel L, Volkow P, Ochoa FJ, et al. (1993). Oral findings in Mexican AIDS patients with cancer. J Oral Pathol Med 22:8791.[Medline]
Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Ponce-de-Leon S, Ponce-de-Leon S (1998). Oral manifestations of HIV infection by gender and transmission category in Mexico City. J Oral Pathol Med 27:135140.[Medline]
Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S (2003). The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine (Baltimore) 82:3950.[Medline]
Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW (2000). Oral lesions and conditions associated with immunodeficiency virus infection in 300 south Indian patients. Oral Dis 6:152157.[Medline]
Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N (2004). Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South-Indian patients. Ann Acad Med Singapore 33(Suppl):3742.[Medline]
Reichart PA, Khongkunthian P, Bendick C (2003). Oral manifestations in HIV-infected individuals from Thailand and Cambodia. Med Microbiol Immunol (Berl) 192:157160.[Medline]
Santos LC, Castro GF, de Souza IP, Oliveira RH (2001). Oral manifestations related to immunosuppression degree in HIV-positive children. Braz Dent J 12:135138.[Medline]
Tukutuku K, Muyembe-Tamfum L, Kayembe K, Odio W, Kandi K, Ntumba M (1990). Oral manifestations of AIDS in a heterosexual population in a Zaire hospital. J Oral Pathol Med 19:232234.[Medline]
UNAIDS (2004). WHO epidemiological fact sheet. UNAIDS/WHO working group on global HIV/AIDS, December. http://www.unaids.org/bangkok2004/GAR2004_html/GAR2004_03_en.htm#P237_35114
Wanzala P, Pindborg JJ (1995). Results of a 3-year longitudinal follow-up of women at high risk of AIDS. In: Oral manifestations of HIV infection: proceedings of the Second International Workshop on the Oral Manifestations of HIV infection, January 31-February 3, 1993, San Francisco, CA, USA. Greenspan JS, Greenspan D, editors. Chicago, IL: Quintessence Publishing Co. Inc., pp. 6872.
This article has been cited by other articles:
![]() |
T.A. Hodgson, D. Greenspan, and J.S. Greenspan Oral Lesions of HIV Disease and HAART in Industrialized Countries Adv. Dent. Res., April 1, 2006; 19(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® | Journal of Dental Research ® | Critical Reviews (1990-2004) |